{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T02:23:16Z","timestamp":1794104596427,"version":"4.8.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.cbi.2026.112389","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:20:30Z","timestamp":1792682430000},"page":"112389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["N-(3-Trifluoromethylphenyl)sulfonyl-indole-3-carbaldehyde thiosemicarbazones induce apoptosis and modulate p53-associated signaling in prostate cancer: integrated experimental and computational studies"],"prefix":"10.1016","volume":"440","author":[{"given":"Khadija-tul","family":"Kubra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zden \u00d6zg\u00fcn","family":"Acar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe Merve","family":"\u015eenol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaattin","family":"\u015een","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil","family":"\u015eenol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazma","family":"Batool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norah A.","family":"Albekairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif","family":"Rasool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4088-8297","authenticated-orcid":false,"given":"Zahid","family":"Shafiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman","family":"Alshammari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.cbi.2026.112389_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111826","article-title":"BCL-xL inhibition potentiates cancer therapies by redirecting the outcome of p53 activation from senescence to apoptosis","volume":"41","author":"Bharti","year":"2022","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.cbi.2026.112389_bib2","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1182\/blood.2022016362","article-title":"Venetoclax and idasanutlin in relapsed\/refractory AML: a nonrandomized, open-label phase 1b trial","volume":"141","author":"Daver","year":"2023","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cbi.2026.112389_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15010026","article-title":"Balance Cell Apoptosis and Pyroptosis of Caspase-3-Activating Chemotherapy for Better Antitumor Therapy","volume":"15","author":"Li","year":"2023","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.cbi.2026.112389_bib4","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.eururo.2024.11.013","article-title":"Recent patterns and trends in global prostate cancer incidence and mortality: an update","volume":"87","author":"Schafer","year":"2025","journal-title":"Eur. Urol."},{"issue":"2","key":"10.1016\/j.cbi.2026.112389_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.prnil.2025.10.001","article-title":"Therapeutic potentials of curcumin in prostate cancer: a comprehensive review of pathways and clinical prospects","volume":"14","author":"5. Fattahi","year":"2026","journal-title":"Prostate International"},{"issue":"1","key":"10.1016\/j.cbi.2026.112389_bib6","first-page":"12","article-title":"Cancer statistics","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cbi.2026.112389_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.fbio.2025.107000","article-title":"Capsaicin functions as an androgen receptor antagonist inhibiting the growth of prostate cancer in cellular and mice models","volume":"69","author":"Zhao","year":"2025","journal-title":"Food Biosci."},{"issue":"4","key":"10.1016\/j.cbi.2026.112389_bib8","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1016\/S2352-3026(22)00403-3","article-title":"Eprenetapopt combined with venetoclax and azacitidine in <em>TP53<\/em>-mutated acute myeloid leukaemia: a phase 1, dose-finding and expansion study","volume":"10","author":"Garcia-Manero","year":"2023","journal-title":"Lancet Haematol."},{"issue":"6","key":"10.1016\/j.cbi.2026.112389_bib9","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.3390\/ijms22062841","article-title":"Co-operativity between MYC and BCL-2 pro-survival proteins in cancer","volume":"22","author":"Fairlie","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.cbi.2026.112389_bib10","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1002\/ptr.8017","article-title":"The efficacy of natural bioactive compounds against prostate cancer: molecular targets and synergistic activities","volume":"37","author":"Mia","year":"2023","journal-title":"Phytother Res."},{"issue":"1","key":"10.1016\/j.cbi.2026.112389_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70666","article-title":"A small indole derivative isolated from caper (Capparis ovata) as an inducer of P53-Mediated apoptosis in prostate cancer: comprehensive in vitro and in silico studies","volume":"40","author":"Acar","year":"2026","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"7","key":"10.1016\/j.cbi.2026.112389_bib12","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1016\/j.apsb.2022.03.021","article-title":"Target-based anticancer indole derivatives and insight into structure\u2012activity relationship: a mechanistic review update (2018-2021)","volume":"12","author":"Dhiman","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.cbi.2026.112389_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116597","article-title":"Indole derivatives as tubulin polymerization inhibitors for the development of promising anticancer agents","volume":"55","author":"Hong","year":"2022","journal-title":"Bioorg. Med. Chem."},{"issue":"19","key":"10.1016\/j.cbi.2026.112389_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29194770","article-title":"Indole derivatives: a versatile scaffold in modern drug Discovery-An updated review on their multifaceted therapeutic applications (2020-2024)","volume":"29","author":"Mo","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2026.112389_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114334","article-title":"Small-molecule MDM2 inhibitors in clinical trials for cancer therapy","volume":"236","author":"Wang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2026.112389_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113334","article-title":"Structural insights of oxindole based kinase inhibitors as anticancer agents: recent advances","volume":"216","author":"Dhokne","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.cbi.2026.112389_bib17","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.3390\/molecules30092077","article-title":"Thiosemicarbazone-based compounds: cancer cell inhibitors with antioxidant properties","volume":"30","author":"Garbuz","year":"2025","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.cbi.2026.112389_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30010129","article-title":"Thiosemicarbazone-based compounds: a promising scaffold for developing antibacterial, antioxidant, and anticancer therapeutics","volume":"30","author":"Czylkowska","year":"2024","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.cbi.2026.112389_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-18735-y","article-title":"Synthesis, antiproliferative activity targeting lung cancer and in silico studies of hydroxypiperidine substituted thiosemicarbazones","volume":"15","author":"Aftab","year":"2025","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.cbi.2026.112389_bib20","doi-asserted-by":"crossref","first-page":"605","DOI":"10.14233\/ajchem.2023.26967","article-title":"Evaluation of anticancer potential of N(4)-Alkyl substituted 5-Methoxyisatin thiosemicarbazones: synthesis, characterization and molecular docking","volume":"35","author":"Chaudhary","year":"2023","journal-title":"Asian J. Chem."},{"issue":"9","key":"10.1016\/j.cbi.2026.112389_bib21","article-title":"Synthesis, characterization, and comprehensive in vitro and in silico evaluation of the anti-inflammatory potential of novel 1,2,3-Triazole-Arylidenehydrazide\/Thiazolidinone hybrids","volume":"358","author":"Pepe","year":"2025","journal-title":"Arch. Pharm. (Weinh.)"},{"key":"10.1016\/j.cbi.2026.112389_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108869","article-title":"Novel thiazolidinedione hybrids as cholinesterase inhibitors and targeting neuroblastoma: design, synthesis, in vitro and in silico biological evaluations","volume":"164","author":"Turgut","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"9","key":"10.1016\/j.cbi.2026.112389_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202500269","article-title":"Therapeutic potential of nitrogen-substituted oleanolic acid derivatives in neuroinflammatory and cytokine pathways: insights from cell-based and computational models","volume":"22","author":"Turgut","year":"2025","journal-title":"Chem. Biodivers."},{"issue":"1","key":"10.1016\/j.cbi.2026.112389_bib24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1021\/acs.jnatprod.2c00798","article-title":"Synthesis and comprehensive in vivo activity profiling of Olean-12-en-28-ol, 3beta-Pentacosanoate in experimental autoimmune encephalomyelitis: a natural remyelinating and anti-inflammatory agent","volume":"86","author":"Senol","year":"2023","journal-title":"J. Nat. Prod."},{"issue":"10","key":"10.1016\/j.cbi.2026.112389_bib25","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1080\/17568919.2025.2504336","article-title":"An insight into the in vivo antitumor therapeutic potential of indole-(fused) pyri(mi)dine hybrids","volume":"17","author":"Xu","year":"2025","journal-title":"Future Med. Chem."},{"issue":"3","key":"10.1016\/j.cbi.2026.112389_bib26","first-page":"410","article-title":"Synthesis and evaluation of naphthalene-based thiosemicarbazone derivatives as new anticancer agents against LNCaP prostate cancer cells","volume":"31","author":"Altintop","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"7","key":"10.1016\/j.cbi.2026.112389_bib27","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1039\/D4MD00302K","article-title":"Design and synthesis of chromene-1, 2, 3-triazole benzene sulfonamide hybrids as potent carbonic anhydrase-IX inhibitors against prostate cancer","volume":"15","author":"Albelwi","year":"2024","journal-title":"RSC Med. Chem."},{"issue":"4","key":"10.1016\/j.cbi.2026.112389_bib28","first-page":"823","article-title":"QSAR, molecular docking, and pharmacokinetic analysis of thiosemicarbazone-indole compounds targeting prostate cancer cells","volume":"19","author":"Kubo","year":"2024","journal-title":"J. Taibah Univ. Med. Sci."},{"key":"10.1016\/j.cbi.2026.112389_bib29","article-title":"Design, synthesis and activity evaluation of benzene sulfonamide derivatives as novel androgen receptor antagonist","volume":"294","author":"Cong","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.cbi.2026.112389_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jics.2024.101229","article-title":"Synthesis and anticancer screening of substituted (phenyl)-1-((naphthalen-5-yl) methylene) thiosemicarbazide against PC3 prostate cancer cells","volume":"101","author":"Anisree","year":"2024","journal-title":"J. Indian Chem. Soc."},{"key":"10.1016\/j.cbi.2026.112389_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112970","article-title":"Design, synthesis and biological evaluation of novel thiosemicarbazone-indole derivatives targeting prostate cancer cells","volume":"210","author":"He","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2026.112389_bib32","article-title":"Exploration of anticancer potency of N (4) thiomorpholinyl isatin\/5-haloisatin thiosemicarbazones on coordination to Cu2+ ion","volume":"143","author":"Singh","year":"2022","journal-title":"Inorg. Chem. Commun."},{"issue":"35","key":"10.1016\/j.cbi.2026.112389_bib33","doi-asserted-by":"crossref","first-page":"30978","DOI":"10.1021\/acsomega.2c02966","article-title":"Pyridine-based NNS tridentate chitosan thiosemicarbazones and their Copper(II) complexes: synthesis, characterization, and anticancer activity","volume":"7","author":"Adhikari","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.cbi.2026.112389_bib34","doi-asserted-by":"crossref","DOI":"10.1039\/D6RA02731H","article-title":"Identification of selective N-pyridinsulfonyl indole based thiosemicarbazone derivatives as potential antiproliferative agents against lung cancer cells","author":"Batool","year":"2026","journal-title":"RSC Adv."},{"issue":"34","key":"10.1016\/j.cbi.2026.112389_bib35","doi-asserted-by":"crossref","first-page":"33196","DOI":"10.1039\/D6RA02731H","article-title":"Identification of selective N-pyridinsulfonyl indole based thiosemicarbazone derivatives as potential antiproliferative agents against lung cancer cells","volume":"16","author":"Batool","year":"2026","journal-title":"RSC Adv."},{"issue":"12","key":"10.1016\/j.cbi.2026.112389_bib36","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1039\/D5CP00275C","article-title":"The influence of fluorine spin-diffusion on 13C solid-state NMR line shapes of CF3 groups","volume":"27","author":"Bartalucci","year":"2025","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"4","key":"10.1016\/j.cbi.2026.112389_bib37","first-page":"100","article-title":"Characterization of six bond carbon-fluorine coupling in 4-FLUOROCHALCONES","volume":"22","author":"Bernhard","year":"2023","journal-title":"Journal of Undergraduate Chemistry Research"},{"issue":"1","key":"10.1016\/j.cbi.2026.112389_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-026-56442-4","article-title":"Synthesis, biological evaluation and detailed computational studies of N-sulfonyl indole-based dihydrothiazoles against colorectal carcinoma","volume":"16","author":"Batool","year":"2026","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.cbi.2026.112389_bib39","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/s41419-018-1128-2","article-title":"Chromatin-remodeling factor, RSF1, controls p53-mediated transcription in apoptosis upon DNA strand breaks","volume":"9","author":"Min","year":"2018","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.cbi.2026.112389_bib40","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/med.22015","article-title":"GADD45A: with or without you","volume":"44","author":"Palomer","year":"2024","journal-title":"Med. Res. Rev."},{"issue":"9","key":"10.1016\/j.cbi.2026.112389_bib41","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012716","article-title":"DNA damage sensing by the ATM and ATR kinases","volume":"5","author":"Mar\u00e9chal","year":"2013","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"2","key":"10.1016\/j.cbi.2026.112389_bib42","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.molcel.2010.09.019","article-title":"The DNA damage response: making it safe to play with knives","volume":"40","author":"Ciccia","year":"2010","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.cbi.2026.112389_bib43","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jaci.2023.12.001","article-title":"MYSM1 attenuates DNA damage signals triggered by physiologic and genotoxic DNA breaks","volume":"153","author":"Mathias","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.cbi.2026.112389_bib44","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41573-022-00558-5","article-title":"Targeting replication stress in cancer therapy","volume":"22","author":"da Costa","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1\u20132","key":"10.1016\/j.cbi.2026.112389_bib45","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/10409238.2024.2344465","article-title":"Elucidating the chain of command: our current understanding of critical target genes for p53-mediated tumor suppression","volume":"59","author":"Indeglia","year":"2024","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"28","key":"10.1016\/j.cbi.2026.112389_bib46","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1038\/onc.2016.502","article-title":"Census and evaluation of p53 target genes","volume":"36","author":"Fischer","year":"2017","journal-title":"Oncogene"},{"issue":"14","key":"10.1016\/j.cbi.2026.112389_bib47","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1158\/0008-5472.CAN-18-3744","article-title":"Bortezomib stabilizes and activates p53 in proliferative compartments of both normal and tumor tissues in vivo","volume":"79","author":"Xue","year":"2019","journal-title":"Cancer Res."},{"issue":"36","key":"10.1016\/j.cbi.2026.112389_bib48","doi-asserted-by":"crossref","first-page":"32018","DOI":"10.1074\/jbc.M504689200","article-title":"Cyclin-dependent kinase inhibitors uncouple cell cycle progression from mitochondrial apoptotic functions in DNA-damaged cancer cells","volume":"280","author":"Le","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.cbi.2026.112389_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003726","article-title":"Characterization of the p53 cistrome \u2013 DNA binding cooperativity dissects p53's tumor suppressor functions","volume":"9","author":"Schlereth","year":"2013","journal-title":"PLoS Genet."},{"issue":"4","key":"10.1016\/j.cbi.2026.112389_bib50","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/emboj.2009.395","article-title":"Coordinated regulation of p53 apoptotic targets BAX and PUMA by SMAR1 through an identical MAR element","volume":"29","author":"Sinha","year":"2010","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.cbi.2026.112389_bib51","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1097-2765(01)00214-3","article-title":"PUMA, a novel proapoptotic gene, is induced by p53","volume":"7","author":"Nakano","year":"2001","journal-title":"Mol. Cell"},{"issue":"1\u20132","key":"10.1016\/j.cbi.2026.112389_bib52","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s10495-022-01780-7","article-title":"BCL-2 protein family: attractive targets for cancer therapy","volume":"28","author":"Kaloni","year":"2023","journal-title":"Apoptosis"},{"key":"10.1016\/j.cbi.2026.112389_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.985363","article-title":"The role of BCL-2 family proteins in regulating apoptosis and cancer therapy","volume":"12","author":"Qian","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.cbi.2026.112389_bib54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"issue":"10","key":"10.1016\/j.cbi.2026.112389_bib55","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/s12276-022-00864-3","article-title":"Molecular targeted therapy for anticancer treatment","volume":"54","author":"Min","year":"2022","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.cbi.2026.112389_bib56","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","article-title":"The MYC oncogene - the grand orchestrator of cancer growth and immune evasion","volume":"19","author":"Dhanasekaran","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cbi.2026.112389_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103756","article-title":"Therapeutic targeting of \"undruggable\" MYC","volume":"75","author":"Llombart","year":"2022","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.cbi.2026.112389_bib58","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"4","key":"10.1016\/j.cbi.2026.112389_bib59","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.molcel.2021.01.033","article-title":"Regulation of PTEN translation by PI3K signaling maintains pathway homeostasis","volume":"81","author":"Mukherjee","year":"2021","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.cbi.2026.112389_bib60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1568009053332627","article-title":"MDM2 is a central node in the p53 pathway: 12 years and counting","volume":"5","author":"Bond","year":"2005","journal-title":"Curr. Cancer Drug Targets"},{"issue":"2","key":"10.1016\/j.cbi.2026.112389_bib61","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrc991","article-title":"Inhibiting the p53\u2013MDM2 interaction: an important target for cancer therapy","volume":"3","author":"Ch\u00e8ne","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.cbi.2026.112389_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202100517","article-title":"The discovery of potential MDM2 inhibitors: a combination of pharmacophore modeling, virtual screening, molecular docking studies, and in vitro\/in vivo biological evaluation","volume":"17","author":"Zhang","year":"2022","journal-title":"ChemMedChem"},{"issue":"2","key":"10.1016\/j.cbi.2026.112389_bib63","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1039\/c2md20208e","article-title":"Identification of novel inhibitors of p53\u2013MDM2 interaction facilitated by pharmacophore-based virtual screening combining molecular docking strategy","volume":"4","author":"Wang","year":"2013","journal-title":"Medchemcomm"},{"issue":"39","key":"10.1016\/j.cbi.2026.112389_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202202380","article-title":"Identifying potential p53-MDM2 interaction antagonists: an integrated approach of pharmacophore-based virtual screening, interaction fingerprinting, MD simulation and DFT studies","volume":"7","author":"Sedzro","year":"2022","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.cbi.2026.112389_bib65","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jmgm.2011.06.003","article-title":"Insight into mechanism of small molecule inhibitors of the MDM2\u2013p53 interaction: molecular dynamics simulation and free energy analysis","volume":"30","author":"Chen","year":"2011","journal-title":"J. Mol. Graph."},{"issue":"1","key":"10.1016\/j.cbi.2026.112389_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70666","article-title":"A small indole derivative isolated from caper (Capparis ovata) as an inducer of P53-Mediated apoptosis in prostate cancer: comprehensive in vitro and in silico studies","volume":"40","author":"Acar","year":"2026","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"5\u20136","key":"10.1016\/j.cbi.2026.112389_bib67","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3109\/10428199709050881","article-title":"MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia","volume":"26","author":"Johnston","year":"1997","journal-title":"Leuk. Lymphoma"},{"issue":"5","key":"10.1016\/j.cbi.2026.112389_bib68","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/leu.2011.28","article-title":"Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21)","volume":"25","author":"Drakos","year":"2011","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.cbi.2026.112389_bib69","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1038\/s41467-023-40087-2","article-title":"Structures of p53\/BCL-2 complex suggest a mechanism for p53 to antagonize BCL-2 activity","volume":"14","author":"Wei","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cbi.2026.112389_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2025.108683","article-title":"Morpholine-modified thiosemicarbazones and thiazolidin-4-ones against Alzheimer's key enzymes: from synthesis to inhibition","volume":"120","author":"Demir","year":"2026","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.cbi.2026.112389_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.144425","article-title":"Design and synthesis of new thienopyrimidine derivatives as potential anticancer agents: from cytotoxicity screening to VEGFR inhibition modeling","volume":"1352","author":"Tokal\u0131","year":"2026","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.cbi.2026.112389_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.109364","article-title":"A series of 4-thiomorpholinophenyl-thiosemicarbazones as cholinesterase inhibitors with anti-neuroblastoma effects","volume":"168","author":"Aftab","year":"2026","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.cbi.2026.112389_bib73","doi-asserted-by":"crossref","DOI":"10.1039\/D5MD00628G","article-title":"2-Oxoindolin-thiazoline hybrids as scaffold-based therapeutics for T2DM-associated cognitive impairment: design, synthesis, in vitro and in silico studies","author":"Qayed","year":"2026","journal-title":"RSC Med. Chem."},{"issue":"3","key":"10.1016\/j.cbi.2026.112389_bib74","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1021\/acsomega.5c08806","article-title":"Four new Perforane-Type sesquiterpenes from Laurencia obtusa (Hudson) J.V. lamouroux as potent lung cancer inhibitors: isolation, structure elucidation, cytotoxicity, molecular docking, dynamics, and ADME studies","volume":"11","author":"Demirk\u0131ran","year":"2026","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.cbi.2026.112389_bib75","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-026-50728-3","article-title":"Synthesis, biological evaluation and molecular docking studies of N-propylsulfonyl indole-linked hydrazinecarbothioamides as selective ecto-5\u2032-nucleotidase and NTPDase inhibitors","volume":"16","author":"Batool","year":"2026","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cbi.2026.112389_bib76","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-026-52909-6","article-title":"Design, synthesis, and multitarget evaluation of thiosemicarbazone\u2013sulfonamide hybrids as potent cholinesterase and MAO-A inhibitors with neuroblastoma-associated cytotoxicity","volume":"16","author":"Abbas","year":"2026","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2026.112389_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.139519","article-title":"Exploring highly selective polymethoxy fenamate isosteres as novel anti-prostate cancer agents: synthesis, biological activity, molecular docking, molecular dynamics, and ADME studies","volume":"1319","author":"Tokal\u0131","year":"2025","journal-title":"J. Mol. Struct."},{"issue":"4","key":"10.1016\/j.cbi.2026.112389_bib78","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/17568919.2026.2620368","article-title":"New quinazolinone-thiazolidinedione hybrids as selective anti-lung cancer agents and promising EGFR inhibitors","volume":"18","author":"Tokal\u0131","year":"2026","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.cbi.2026.112389_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2026.145703","article-title":"Design and synthesis of polymethoxy rhodanines as selective small-molecule candidates for breast cancers","volume":"1361","author":"Tokal\u0131","year":"2026","journal-title":"J. Mol. Struct."},{"issue":"10","key":"10.1016\/j.cbi.2026.112389_bib80","doi-asserted-by":"crossref","first-page":"8807","DOI":"10.1039\/D5RA10080A","article-title":"Synthesis, multi-target evaluation and DFT analysis of 6-hydroxychromone derived hydrazones with carbonic anhydrase I\u2013II\/acetylcholinesterase inhibition and antioxidant activity","volume":"16","author":"Zareen","year":"2026","journal-title":"RSC Adv."},{"key":"10.1016\/j.cbi.2026.112389_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2026.146575","article-title":"4-(2,4-dichlorobenzamido)-benzohydrazide derivatives and their elastic liposomal formulations for cholinesterase and neuroblastoma inhibition: a comprehensive in vitro and in silico study","volume":"1372","author":"\u00c7ak\u0131r","year":"2026","journal-title":"J. Mol. Struct."},{"issue":"11","key":"10.1016\/j.cbi.2026.112389_bib82","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70055","article-title":"Lactoperoxidase inhibition of celecoxib derivatives containing the pyrazole linked-sulfonamide moiety: antioxidant capacity, antimicrobial activity, and molecular docking studies","volume":"38","author":"Bayrak","year":"2024","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"33","key":"10.1016\/j.cbi.2026.112389_bib83","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202301727","article-title":"Indole-3-carbinol (I3C): inhibition effect on monoamine oxidase A (MAO-A), monoamine oxidase B (MAO-B) and cholinesterase enzymes, antioxidant capacity and molecular docking study","volume":"8","author":"Binici","year":"2023","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.cbi.2026.112389_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2021.107565","article-title":"Cholinesterases, carbonic anhydrase inhibitory properties and in silico studies of novel substituted benzylamines derived from dihydrochalcones","volume":"94","author":"Akincioglu","year":"2021","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.cbi.2026.112389_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.109252","article-title":"Dual targeting of neuroblastoma and cholinesterase by morpholino\/pyrrolidino-sulfonyl-indole thiosemicarbazones: synthesis, characterization, enzyme inhibition, cytotoxicity, docking and dynamics studies","author":"Batool","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.cbi.2026.112389_bib86","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.bmc.2016.11.015","article-title":"Computer design, synthesis, and bioactivity analyses of drugs like fingolimod used in the treatment of multiple sclerosis","volume":"25","author":"Turgut","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.cbi.2026.112389_bib87","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2478\/jtim-2020-0027","article-title":"Suppression of inflammatory cytokines expression with bitter melon (Momordica charantia) in TNBS-instigated ulcerative colitis","volume":"8","author":"Semiz","year":"2020","journal-title":"J. Transl. Intern. Med."},{"issue":"4","key":"10.1016\/j.cbi.2026.112389_bib88","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.cbi.2026.112389_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fpls.2020.601316","article-title":"Docking characterization and in vitro inhibitory activity of Flavan-3-ols and dimeric proanthocyanidins against the main protease activity of SARS-Cov-2","volume":"11","author":"Zhu","year":"2020","journal-title":"Front. Plant Sci."},{"issue":"6","key":"10.1016\/j.cbi.2026.112389_bib90","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.70033","article-title":"Quinazolin-4(3H)-One-Based new glitazones as dual inhibitors of \u03b1-Glucosidase and aldose reductase: comprehensive approaches for managing diabetes mellitus and its complications","volume":"358","author":"Tokal\u0131","year":"2025","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.cbi.2026.112389_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2026.109778","article-title":"Targeting cholinergic dysfunction and neuroinflammation through rationally designed Thieno[3,2-d]pyrimidine hybrids","volume":"175","author":"Tokal\u0131","year":"2026","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.cbi.2026.112389_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2025.108486","article-title":"Synthesis and evaluation of aldose reductase inhibition of new thiazolidine-quinazoline hybrids through in vitro and in silico approaches","volume":"118","author":"\u015eenol","year":"2025","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.cbi.2026.112389_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2025.117189","article-title":"Detection and in silico evaluation of undeclared venlafaxine and clomethiazole in a counterfeit herbal product marketed for alcohol withdrawal syndrome","volume":"268","author":"Arslan","year":"2026","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.cbi.2026.112389_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2026.146223","article-title":"Multi-target vanillin-derived hydrazones: cholinesterase and MAO-A inhibition, antioxidant activity and molecular modeling toward alzheimer's disease","author":"Fatima","year":"2026","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.cbi.2026.112389_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140937","article-title":"New 4-methanesulfonyloxy benzohydrazide derivatives as potential antioxidant and carbonic anhydrase I and II inhibitors: synthesis, characterization, molecular docking, dynamics & ADME studies","volume":"1325","author":"K\u00f6se","year":"2025","journal-title":"J. Mol. Struct."},{"issue":"n\/a","key":"10.1016\/j.cbi.2026.112389_bib96","article-title":"Therapeutic potential of nitrogen-substituted oleanolic acid derivatives in neuroinflammatory and cytokine pathways: insights from cell-based and computational models","author":"\u00c7elik Turgut","year":"2025","journal-title":"Chem. Biodivers. n\/a"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279726004977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279726004977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T01:25:57Z","timestamp":1794101157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279726004977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":96,"alternative-id":["S0009279726004977"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2026.112389","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-(3-Trifluoromethylphenyl)sulfonyl-indole-3-carbaldehyde thiosemicarbazones induce apoptosis and modulate p53-associated signaling in prostate cancer: integrated experimental and computational studies","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2026.112389","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112389"}}